NDC 70518-0786-2 - Losartan Potassium and Hydrochlorothiazide
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-0786
- Requested NDC
- 70518-0786-2
- Package NDCs from labels
- 70518-0786-0, 70518-0786-2, 70518-0786-1
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2024-02-13
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide - REMEDYREPACK INC. | REMEDYREPACK INC. | 2024-02-13 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | e8ca7334-4b58-4f4b-bf36-0ab47b60ff7c | 2020-12-14 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 435c5544-491b-476a-b950-712b2c18e334 | 2020-12-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Triamterene and Hydrochlorothiazide | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 191b9e48-7d44-4378-9f3f-b4a999080c8c | 2020-11-12 | Warnings, Adverse reactions | 0J48LPH2TH |
| Fosinopril Sodium and Hydrochlorothiazide | FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE | CIPLA USA INC. | 4e1ed7da-029e-48d6-a5e4-fc7ac11192fb | 2020-11-03 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | ec70ea28-a219-45d1-9d5b-6a79c7ef4987 | 2020-10-28 | Warnings, Adverse reactions | 0J48LPH2TH |
| LOSARTAN POTASSIUM | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | 2f738295-53d6-4d4f-8864-9faf893dbdf2 | 2020-10-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Losartan Potassium | LOSARTAN POTASSIUM | Aphena Pharma Solutions - Tennessee, LLC | be2432ba-2118-418a-addf-56db9b6c39d2 | 2020-10-07 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | 841b7962-bf5d-4c45-b594-80b17ba5187d | 2020-09-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Vaseretic | ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE | Bausch Health US, LLC | bf3007e2-8fcc-48de-8fd5-55e95033d62f | 2020-08-31 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Candesartan Cilexetil and Hydrochlorothiazide | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | Mylan Pharmaceuticals Inc. | f3c4f7ed-e667-4528-a675-b032c2a4425d | 2020-08-15 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 0fdb6713-8013-4cfe-a776-0c1e9414a91c | 2020-06-02 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Solco Healthcare U.S., LLC | 60c97ab9-b25e-4ea5-a159-792292178c65 | 2020-05-20 | Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | ScieGen Pharmaceuticals, Inc. | 02e96a51-1d56-460c-8c20-3d6f37e0ce46 | 2020-05-11 | Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE | Actavis Pharma, Inc. | ab5e9ae4-e575-4a63-99f3-2bde36bdd508 | 2020-05-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Lisinopril and Hydrochlorothiazide | LISINOPRIL AND HYDROCHLOROTHIAZIDE TABLETS | Aphena Pharma Solutions - Tennessee, LLC | e2903227-4a79-4a9c-b96b-073b8e41fb01 | 2020-01-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 33710c3c-6f17-457a-8665-04c23bca8b75 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | ANDA091617 979464 3ST302B24A 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | a06ee3c1-bd0d-4dda-a453-1655eebffdae | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Losortan Potassium | LOSARTAN POTASSIUM | Proficient Rx LP | 364fe10e-11ca-4ee6-9f67-c85dec09aca5 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 3ST302B24A |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 411caa05-5eff-4285-a940-7f6d2429ba81 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Valsartan and Hydrochlorothiazide | VALSARTAN AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | e1f94546-c71c-4175-9384-20238181e05f | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.